-
-
-
-
-
-
-
Biogen earnings preview Q4: set for weaker print, Leqembi outlook in focus
-
-
-
-
-
-
-
Biogen (BIIB) Tops Q3 EPS by 93c; updates guidance
-
-
-
-
-
-
-
U.S. large biotech stocks Q2 earnings preview
-
-
-
-
-
-
-
HSBC cuts biotech stocks: Eli Lilly lowered to Reduce
-
-
-
-
-
-
-
Biogen (BIIB) PT Lowered to $255 at Oppenheimer
-
-
-
-
-
-
-
Biogen (BIIB) Announces CFO Retirement
-
-
-
-
-
-
-
Midday movers: Bristol-Myers, 3M and Deckers rise; Dexcom falls
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

